Gf Fund Management Co., Ltd. - CSI Hong Kong Brand Name Drug Index ETF (SHA:513120)
1.097
+0.003 (0.27%)
At close: Jun 20, 2025, 2:57 PM CST
SHA:513120 Holdings List
As of Dec 31, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 1801 | Innovent Biologics, Inc. | 10.02% |
2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 9.89% |
3 | BEIGF | BeOne Medicines Ltd. | 9.49% |
4 | HKG: 9926 | Akeso, Inc. | 8.47% |
5 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 7.57% |
6 | HKG: 1177 | Sino Biopharmaceutical Limited | 7.01% |
7 | n/a | Cash | 6.25% |
8 | HKG: 9688 | Zai Lab Limited | 4.28% |
9 | HKG: 2359 | WuXi AppTec Co., Ltd. | 4.25% |
10 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.98% |
11 | HKG: 1548 | Genscript Biotech Corporation | 2.87% |
12 | 13.HK | HUTCHMED (China) Ltd | 2.67% |
13 | HKG: 1530 | 3SBio Inc. | 2.26% |
14 | HKG: 0867 | China Medical System Holdings Limited | 2.13% |
15 | HKG: 1952 | Everest Medicines Limited | 1.79% |
16 | SHPMF | Shanghai Pharmaceuticals Holding Co., Ltd | 1.75% |
17 | INCPF | InnoCare Pharma Ltd | 1.74% |
18 | HKG: 0512 | Grand Pharmaceutical Group Limited | 1.60% |
19 | HKG: 2196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.50% |
20 | HKG: 2096 | Simcere Pharmaceutical Group Limited | 1.39% |
21 | HKG: 2268 | WuXi XDC Cayman Inc. | 1.37% |
22 | HKG: 6855 | Ascentage Pharma Group International | 1.33% |
23 | HKG: 2162 | Keymed Biosciences Inc. | 1.18% |
24 | HKG: 2186 | Luye Pharma Group Ltd. | 1.12% |
25 | HKG: 1558 | YiChang HEC ChangJiang Pharmaceutical Co., Ltd. | 0.85% |
26 | LVZPF | Livzon Pharmaceutical Group Inc Class H | 0.82% |
27 | HKG: 3347 | Hangzhou Tigermed Consulting Co., Ltd | 0.74% |
28 | PHBBF | Pharmaron Beijing Co Ltd Ordinary Shares - Class H | 0.73% |
29 | HKG: 6185 | CanSino Biologics Inc. | 0.65% |
30 | HKG: 2228 | XtalPi Holdings Limited | 0.60% |
31 | HKG: 6660 | AIM Vaccine Co., Ltd. | 0.57% |
32 | HKG: 9995 | RemeGen Co., Ltd. | 0.53% |
33 | HKG: 2171 | CARsgen Therapeutics Holdings Limited | 0.43% |
34 | HKG: 2157 | Lepu Biopharma Co., Ltd. | 0.41% |
35 | SHJBF | Shanghai Junshi Biosciences Co., Ltd. | 0.39% |
36 | HKG: 9966 | Alphamab Oncology | 0.31% |
37 | HKG: 6821 | Asymchem Laboratories (Tianjin) Co., Ltd. | 0.28% |
38 | HKG: 6127 | Joinn Laboratories(China)Co.,Ltd. | 0.22% |
39 | HKG: 1167 | Jacobio Pharmaceuticals Group Co., Ltd. | 0.03% |
40 | HKG: 2137 | Brii Biosciences Limited | 0.02% |
41 | HKG: 9939 | Kintor Pharmaceutical Limited | 0.02% |
42 | HKG: 2197 | Clover Biopharmaceuticals, Ltd. | 0.00% |
43 | HKG: 2511 | HighTide Therapeutics, Inc. | 0.00% |
44 | n/a | Other Assets And Liabilities | -3.53% |
As of Dec 31, 2024